InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Angotti Vincent J., Chairman & CEO. Director active across 1 companies, notably Acelrx Pharmaceuticals INC. Cumulatively, 5 reports have been recorded. Total volume traded: €10k. The latest transaction was disclosed on 7 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€9,65946,400 shares@ €0.208225.0% of flow
Common Stock
SEC:0001209191-22-035010:0·
Ideal exit: 4 Mar 2023 (T+270)
€8,43823,051 shares@ €0.366121.8% of flow
Common Stock
SEC:0001209191-22-016238:0·
0390,000 shares0
Common Stock
SEC:0001209191-22-009343:0·
€10,30127,318 shares@ €0.3771100.0% of flow
Common Stock
SEC:0001209191-22-007622·
€10,30127,318 shares@ €0.377126.6% of flow
Common Stock
SEC:0001209191-22-007622:0·
5 of 5 declarations
About Angotti Vincent J.
Vincent J. Angotti is the Chief Executive Officer of AcelRx Pharmaceuticals Inc. He is responsible for the strategic direction of the company and the management of its operations. With experience in the pharmaceutical sector, he is committed to promoting innovation and enhancing the therapeutic solutions offered by the company.
